Shiva Malek
Associate Director, Biochemical and Cellular Pharmacology
"I am inspired by cancer survivors and their ability to face the unknown with courage, strength, and a will to live. The pictures and stories of patients whose lives we have positively impacted is a source of motivation for me."
- 7
years at Genentech - 5
publications (2010-12) - 6
awards & honors
I came to Genentech in 2006 to help build the growing small molecule drug discovery group, having spent a number of years at smaller biotechnology companies including Vertex Pharmaceuticals and Exelixis.
I am thrilled to be a part of this dynamic department and hope to contribute to Genentech's success in the small molecule arena.
I was born in Iran and moved to the United States when I was 7 years old. Our summer vacation to Logan, Utah in 1978 resulted in a permanent move to the United States. We moved to California in the early 80's and I was lucky enough to take advantage of the University of California system from undergraduate through my Ph.D.
Featured Publication
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.
Nature 2010 Feb 3. [Epub ahead of print]
Hatzivassiliou G, Song K, Yen I, Brandhuber BJ, Anderson DJ, Alvarado R, Ludlam MJ, Stokoe D, Gloor SL, Vigers G, Morales T, Aliagas I, Liu B, Sideris S, Hoeflich KP, Jaiswal BS, Seshagiri S, Koeppen H, Belvin M, Friedman LS, Malek S.
View Abstract on PubMed
